Belpointe Asset Management’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-937
Closed -$75.6K 1773
2023
Q1
$75.6K Buy
937
+143
+18% +$11.5K ﹤0.01% 1471
2022
Q4
$59.4K Buy
+794
New +$56.5K ﹤0.01% 1503
2022
Q1
Sell
-2,151
Closed -$165K 1254
2021
Q4
$165K Sell
2,151
-39
-2% -$2.87K 0.01% 974
2021
Q3
$161K Sell
2,190
-136
-6% -$10.2K 0.01% 950
2021
Q2
$155K Buy
+2,326
New +$155K 0.01% 936
2021
Q1
Sell
-8,420
Closed -$613K 1031
2020
Q4
$613K Buy
+8,420
New +$594K 0.06% 353

Other funds holding HOLX

Belpointe Asset Management's HOLX Position: Q2 2023 in Review

Belpointe Asset Management sold out of Hologic (HOLX) in Q2 2023, closing a stake of 937 shares — an estimated $75.6K sold.

Belpointe Asset Management first reported a position in HOLX in Q4 2020 and held it in 6 quarters. The position peaked at $613K in Q4 2020. 713 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Belpointe Asset Management reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 937 Hologic shares in Q2 2023, an estimated $75.6K.
  • Belpointe Asset Management first reported a position in Hologic in Q4 2020 and held it in 6 quarters.
  • Belpointe Asset Management's Hologic position peaked at $613K in Q4 2020.
  • 713 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.